
Ovid Therapeutics OVID
€ 1.39
-2.41%
Quartalsbericht 2025-Q3
hinzugefügt 12.11.2025
Ovid Therapeutics DSO 2011-2026 | OVID
DSO Jährlich Ovid Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 4.1 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 4.1 | 4.1 | 4.1 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Apellis Pharmaceuticals
APLS
|
115 | $ 20.32 | -1.86 % | $ 2.56 B | ||
|
Aptorum Group Limited
APM
|
20.6 | $ 0.82 | -2.7 % | $ 4.47 M | ||
|
Axsome Therapeutics
AXSM
|
105 | $ 165.39 | -0.6 % | $ 8.23 B | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
AbCellera Biologics
ABCL
|
173 | $ 3.65 | -4.58 % | $ 1.09 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Adverum Biotechnologies
ADVM
|
222 | - | - | $ 86.2 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | ||
|
Capricor Therapeutics
CAPR
|
31.9 | $ 25.62 | -4.62 % | $ 686 M | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
Codexis
CDXS
|
32.9 | $ 0.99 | -2.59 % | $ 72.7 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
4.13 | $ 3.18 | -4.94 % | $ 1.14 M | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Agios Pharmaceuticals
AGIO
|
47.4 | $ 28.47 | -2.5 % | $ 1.65 B | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
Фармсинтез
LIFE
|
209 | - | - | - | ||
|
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | ||
|
Cellectis S.A.
CLLS
|
94.5 | $ 3.64 | -4.21 % | $ 116 M | ||
|
Altimmune
ALT
|
15.1 K | $ 4.15 | -0.24 % | $ 295 M | ||
|
Teligent, Inc.
TLGT
|
90.7 | - | -13.85 % | $ 16.1 M | ||
|
Viela Bio, Inc.
VIE
|
169 | - | - | $ 2.91 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
59.5 | $ 24.06 | 0.75 % | $ 2.94 B | ||
|
Amarin Corporation plc
AMRN
|
213 | $ 13.95 | 0.14 % | $ 5.79 B | ||
|
AbbVie
ABBV
|
258 | $ 231.93 | -0.98 % | $ 410 B | ||
|
Blueprint Medicines Corporation
BPMC
|
42.5 | - | - | $ 8.14 B |